Life After COVID-19
Karen Larimer, physIQ's Director of Clinical Development, discusses how we should be taking advantage of digital technologies to get to "life after COVID-19."
Whether you're a health system in need of a way to care for patients at home or a biopharma company searching for a solution to keep your trials going, physIQ's clinical-grade platform and FDA-cleared analytics are ready to scale to support patients and clinicians during this crisis.
Karen Larimer, physIQ's Director of Clinical Development, discusses how we should be taking advantage of digital technologies to get to "life after COVID-19."
At physIQ, we welcome the opportunity to speak with potential customers, partners or anyone with an interest in learning more about the transformative potential of our technology.
Contact Us